These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11792128)

  • 1. Statins and mortality.
    Muntwyler J; Gutzwiller F
    Eur Heart J; 2002 Feb; 23(3):183-4. PubMed ID: 11792128
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lower, lower, lower. The LDL goal value of 200 mg/dl is still much too high].
    Einecke D
    MMW Fortschr Med; 2004 Mar; 146(13):4-5. PubMed ID: 15219114
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of pravastatin on coronary events in 2073 patients with low levels of both low-density lipoprotein cholesterol and high-density lipoprotein cholesterol: results from the LIPID study.
    Colquhoun D; Keech A; Hunt D; Marschner I; Simes J; Glasziou P; White H; Barter P; Tonkin A;
    Eur Heart J; 2004 May; 25(9):771-7. PubMed ID: 15120888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. The Prospective Pravastatin Pooling project.
    Simes J; Furberg CD; Braunwald E; Davis BR; Ford I; Tonkin A; Shepherd J
    Eur Heart J; 2002 Feb; 23(3):207-15. PubMed ID: 11792135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercholesterolemia. The evidence supports use of statins.
    Aronow WS
    Geriatrics; 2003 Aug; 58(8):18-20, 26-8, 31-2. PubMed ID: 12938249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness of pravastatin for primary prevention of coronary artery disease in Japan.
    Nagata-Kobayashi S; Shimbo T; Matsui K; Fukui T
    Int J Cardiol; 2005 Sep; 104(2):213-23. PubMed ID: 16168816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphism of the cholesteryl ester transfer protein gene.
    Goldstein MR
    N Engl J Med; 1998 May; 338(22):1624-5; author reply 1625-6. PubMed ID: 9606120
    [No Abstract]   [Full Text] [Related]  

  • 8. Intensive statin therapy in coronary artery disease: is lower cholesterol better and safe?
    Seshasai SR; Ray KK
    Future Cardiol; 2009 Mar; 5(2):129-39. PubMed ID: 19371188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMG CoA reduction in patients with average cholesterol concentrations.
    Braunwald E; Sacks FM; Pfeffer MA; Ridker PM
    Clin Chem; 2011 Jul; 57(7):1072-3. PubMed ID: 21519035
    [No Abstract]   [Full Text] [Related]  

  • 10. Optimal lipids, statins, and dementia.
    Lavie CJ; Milani RV
    J Am Coll Cardiol; 2005 Mar; 45(6):963-4; author reply 964-5. PubMed ID: 15766838
    [No Abstract]   [Full Text] [Related]  

  • 11. Pravastatin therapy is associated with reduction in coronary allograft vasculopathy in pediatric heart transplantation.
    Mahle WT; Vincent RN; Berg AM; Kanter KR
    J Heart Lung Transplant; 2005 Jan; 24(1):63-6. PubMed ID: 15653381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased plasma and cardiac matrix metalloproteinase activities in patients with coronary artery disease and treated with pravastatin.
    Fujiwara T; Saito S; Osanai T; Kameda K; Abe N; Higuma T; Yokoyama J; Hanada H; Fukui K; Fukuda I; Okumura K
    Eur J Pharmacol; 2008 Oct; 594(1-3):146-51. PubMed ID: 18703045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intensive lipid lowering on progression of coronary atherosclerosis: evidence for an early benefit from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial.
    Nissen SE
    Am J Cardiol; 2005 Sep; 96(5A):61F-68F. PubMed ID: 16126025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treating low HDL-cholesterol in normocholesterolaemic patients with coronary disease: statins, fibrates or horses for courses?
    Watts GF
    Eur Heart J; 2004 May; 25(9):716-9. PubMed ID: 15120879
    [No Abstract]   [Full Text] [Related]  

  • 15. [Primary and secondary prevention of coronary disease by statins].
    Ferrières J
    Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):128-36. PubMed ID: 12555337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival, graft atherosclerosis, and rejection incidence in heart transplant recipients treated with statins: 5-year follow-up.
    Stojanovic I; Vrtovec B; Radovancevic B; Radovancevic R; Yazdanbakhsh AP; Thomas CD; Frazier OH
    J Heart Lung Transplant; 2005 Sep; 24(9):1235-8. PubMed ID: 16143239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins and renal function. Is the compound and dose making a difference?
    Athyros VG; Karagiannis A; Kakafika A; Elisaf M; Mikhailidis DP
    Nephrol Dial Transplant; 2007 Mar; 22(3):963-4; author reply 964. PubMed ID: 17255130
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular basis of differences among statins and a comparison with antioxidant vitamins.
    Mason RP
    Am J Cardiol; 2006 Dec; 98(11A):34P-41P. PubMed ID: 17126678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of primary and secondary prevention trials with lovastatin, pravastatin, and simvastatin.
    Gotto AM
    Am J Cardiol; 2005 Sep; 96(5A):34F-38F. PubMed ID: 16126021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expected versus observed survival in 3 large population studies with HMG-CoA reductase inhibitors.
    Naslafkih A; Sestier F
    J Insur Med; 2000; 32(3):155-62. PubMed ID: 15912915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.